Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
cancer
cancer immunotherapy
3
×
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
astrazeneca
biogen
car-t immunotherapy
deals
What
bio
drug
roundup
companies
nash
news
alzheimer’s
annual
approval
approved
assessed
attention
biogen’s
biopharmaceutical
biotech
communities
conference
convo
digital
disease
earlier
epidemic
esmo
europe
failures
fatty
fda
frenzied
germany
growing
hosted
investment
known
led
littered
liver
merck
munich
new
price
Language
Current search:
abbvie
×
" bristol-myers squibb "
×
" cancer immunotherapy "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More